Search - tctmd.com

Displaying 701 - 720 of 6719

Sort: Relevancy | Date

Presentation THT Abstracts 2025

Gender Disparities in the Association of Low Dietary Protein Intake With Congestive Heart Failure: An Analysis of the NHANES Database 2017-2020

Presenter: Phuuwadith Wattanachayakul

February 11, 2025

Presentation THT Abstracts 2025

Clinical Outcomes Among Patients With HFpEF and Peripheral Arterial Disease Undergoing Revascularization

Presenter: Phuuwadith Wattanachayakul

February 11, 2025

Presentation THT Abstracts 2025

Disparities in MDD Incidence Between HFpEF and HFrEF Patients

Presenter: Ibrahim Kamel

February 11, 2025

Presentation THT Abstracts 2025

Evaluating the Impact of Sglt2 Inhibitors on Outcomes in Patients With Sarcoidosis and Heart Failure With Preserved Ejection Fraction

Presenter: Emmanuel Otabor

February 11, 2025

Presentation THT 2025

Patient Selection Protocols and Care Pathways within an Advanced Heart Failure Program

Presenter: Richa Gupta

February 11, 2025

Presentation THT 2025

Residual Risk in HFpEF and the Potential Role of Interatrial Shunts

Presenter: Javed Butler

February 11, 2025

Presentation THT 2025

Real-world Results with Barostim within a Multi-disciplinary Heart Failure Program

Presenter: Patrick McCann

February 11, 2025

Presentation THT 2025

What is the Long-Term Impact of Interatrial Shunting on Right Heart Function?

Presenter: JoAnn Lindenfeld

February 11, 2025

Presentation THT 2025

What Lessons Can We Learn from DanGer in the Management of HF-CS

Presenter: Jacob Abraham

February 11, 2025

Presentation THT 2025

Interatrial versus Coronary Sinus Shunting: Device and Procedural Comparisons

Presenter: Kamran Muhammad

February 11, 2025

Presentation THT 2025

Discuss Escalation Strategies for Patients in HF-CS

Presenter: Jane Wilcox

February 11, 2025

Presentation THT 2025

What Endpoints are Relevant for Evaluating how Interatrial Shunts Provide Clinical Benefit: Hemodynamic Exercise Testing and Beyond

Presenter: Sanjiv Shah

February 11, 2025

Presentation THT 2025

Drug and Device Therapies to Target the Neurohormonal Cascade

Presenter: Rajeev Mohan

February 11, 2025

Presentation THT 2025

Explain the Importance of Timely Identification of Patients in Heart Failure-Cardiogenic Shock (HF-CS)

Presenter: Navin Kapur

February 11, 2025

Presentation THT 2025

Position 1: It Should be Class IIa

Presenter: Manreet Kanwar

February 11, 2025

Presentation THT 2025

Position 2: It Should be Class I

Presenter: Navin Kapur

February 11, 2025

News Daily News

Intravascular Imaging During PCI Should Be a Performance Metric, Researchers Say

Todd Neale

February 11, 2025

Presentation THT 2025

The Best Thing Since Sliced Bread.

Presenter: William Abraham

February 11, 2025

Presentation THT 2025

A Strategy That Has Created More Confusion Than Clarity.

Presenter: Milton Packer

February 11, 2025

Presentation THT 2025

Impact of Obesity Severity on the Effects of Tirzepatide in HFpEF: The SUMMIT Trial

Presenter: Barry Borlaug

February 11, 2025

Advertisement

Gender Disparities in the Association of Low Dietary Protein Intake With Congestive Heart Failure: An Analysis of the NHANES Database 2017-2020

Clinical Outcomes Among Patients With HFpEF and Peripheral Arterial Disease Undergoing Revascularization

Disparities in MDD Incidence Between HFpEF and HFrEF Patients

Evaluating the Impact of Sglt2 Inhibitors on Outcomes in Patients With Sarcoidosis and Heart Failure With Preserved Ejection Fraction

Patient Selection Protocols and Care Pathways within an Advanced Heart Failure Program

Residual Risk in HFpEF and the Potential Role of Interatrial Shunts

Real-world Results with Barostim within a Multi-disciplinary Heart Failure Program

What is the Long-Term Impact of Interatrial Shunting on Right Heart Function?

What Lessons Can We Learn from DanGer in the Management of HF-CS

Interatrial versus Coronary Sinus Shunting: Device and Procedural Comparisons

Discuss Escalation Strategies for Patients in HF-CS

What Endpoints are Relevant for Evaluating how Interatrial Shunts Provide Clinical Benefit: Hemodynamic Exercise Testing and Beyond

Drug and Device Therapies to Target the Neurohormonal Cascade

Explain the Importance of Timely Identification of Patients in Heart Failure-Cardiogenic Shock (HF-CS)

Position 1: It Should be Class IIa

Position 2: It Should be Class I

Intravascular Imaging During PCI Should Be a Performance Metric, Researchers Say

The Best Thing Since Sliced Bread.

A Strategy That Has Created More Confusion Than Clarity.

Impact of Obesity Severity on the Effects of Tirzepatide in HFpEF: The SUMMIT Trial

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content